Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Dobutamine and Regadenoson Stress CMR

NCT00763035 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT00763035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00763035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Dobutamine and Regadenoson Stress CMR
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 1
Overall status
Terminated
Start date
January 31, 2009
Completion date
March 31, 2011
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angina, asthma, chronic obstructive pulmonary disease (copd), coronary artery disease